Urine Test For Cancer Under Development

Scientists are developing a test that, for the first time, is allowing them to monitor urine for chemical indicators of cancer. It is hoped the test may one day allow early screening, even telling patients what type of cancer they have and its stage of advancement. The researchers say treatment progress might be monitored with the same test.

The highly sensitive technique will be detailed in the April 1 print edition of the peer- reviewed journal Analytical Chemistry, published by the American Chemical Society (ACS), the world's largest scientific society. ACS Web publication of this paper occurred on Feb. 20.

The test looks for derivatives of a class of heterocyclic chemical compounds called pteridines. Pteridine derivatives play important roles in normal cell metabolism, such as mediating the action of crucial enzymes and helping to synthesize some vitamins, according to author Yinfa Ma, Ph.D., of Truman State University in Kirksville, Mo. But Ma, who collaborated on this study with scientists from the Chinese Academy of Sciences, says that malignant tumors appear to "greatly disturb the biosynthesis and metabolism of pteridines." He wanted to see if he could detect, and make sense of, those changes.

Ma analyzed the amounts of eight different pteridine derivatives in cancer patients' urine and found that "each type of tumor shows its own pattern in changes of pteridine concentrations." This suggests it may be possible to diagnose a particular cancer by looking at a person's urine sample.

Although the metabolic importance of pteridines has been known for decades, Ma says their mechanisms are not fully understood because of difficulties in determining their levels. He claims current quantification methods are too time-consuming, not cost effective, and provide poor separation of similarly structured pteridine derivatives. Ma's group tested urine samples by first separating derivatives with high-performance capillary electrophoresis, th

Contact: Charmayne Marsh
American Chemical Society

Page: 1 2

Related biology news :

1. Powerful Anti-AIDS Agent Found In Tears And In Urine Of Pregnant Women
2. Urine Tests Will Do Better Than Pelvic Exams To Save Teens From Serious Effects Of Sexually Transmitted Diseases, UCSF Analysis Shows
3. Major New Study Shows HIV-1 Antibodies Found In Urine
4. Results Of Poisoning Visible In Urine
5. Researchers Identify Protein Critical To Urine Concentration
6. Chlamydia Testing Of Urine Samples Can Be Successful
7. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
8. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
9. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
10. Cancer gene MYC emerging as key research target
11. Cancer patient, heal thyself

Post Your Comments:

(Date:3/2/2020)... (PRWEB) , ... March 02, 2020 , ... Philadelphia IP ... W. Bliss, Ph.D., J.D. has joined the firm as a Partner, and Stephany G. ... is an experienced patent attorney and will be a partner in the firm’s biotechnology ...
(Date:3/2/2020)... ... 2020 , ... Rigaku Corporation is pleased to ... Applied Spectroscopy ( Pittcon 2020 ), being held March 1 - 5, at ... exposition on laboratory science, attracting attendees from industry, academia and government from over ...
(Date:2/28/2020)... ... February 26, 2020 , ... ... Rebound PRF® devices are now available to veterinary practices through Covetrus. Enso ... that will provide the most affordable, easiest to use, multi-species validated, platelet-rich ...
Breaking Biology News(10 mins):
(Date:3/19/2020)... ... 2020 , ... Family counsellors, marriage/couples therapists, and those interested ... their perceptions of events. Imagine if a couple’s counsellor could see the impact ... the level of engagement of each individual in the therapeutic process, then tailor ...
(Date:3/12/2020)... MANNHEIM, Germany (PRWEB) , ... March 12, 2020 ... ... leading innovator of atomic force microscopy (AFM) technology, increases the business investment in ... Mannheim, Germany. , The Grand Opening Ceremony of the new Nanoscience Center ...
(Date:3/10/2020)... HOUSTON, Tex. (PRWEB) , ... ... ... Solutions, a full-service cold chain biopharmaceutical engineering firm, is pleased to ... primary focus is on combination medical device qualification and validation in the ...
(Date:3/4/2020)... England (PRWEB) , ... March ... ... Ltd. , an industry-leading provider of recombinant antibody products and services, today ... offers customers the flexibility to rapidly express a large number of antibodies ...
Breaking Biology Technology:
Cached News: